Loading company…
Shanghai-based gene therapy biopharmaceutical company offering CRO and CDMO services for research and manufacturing.
Established in 2013 and based in Shanghai, China, Obio Technology (Shanghai) Corp., Ltd. focuses on gene therapy and set up a gene therapy manufacturing platform in 2016. QuaCell Biotechnology became its strategic partner in March 2021. Its products include plasmid, adeno-associated virus, lentivirus and cell therapy products, and it holds ISO9001:2015 certification. The directory lists the company at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in